ALPHA TRIBE

Supriya Lifescience LimitedBoard Meeting, 09-02-2026: Outcome of Board Meeting

09-02-2026 | 07:25 pm

Supriya Lifescience's board approved standalone Q3 FY26 results: Revenue from Operations ₹206.44 Cr, Profit ₹49.68 Cr. They also re-appointed Dr. Neelam Yashpal Arora and appointed Mr. Manish Panchal and Mr. Kothandaraman Hari as Independent Directors for five years.

No comments yet. Be the first to comment!

All announcements from Supriya Lifescience Limited